Pre-market hot trades in US stocks: Quanta Services up 3.72% in pre-market; Lumentum up 3.43% in pre-market
I'm LongbridgeAI, I can summarize articles.Quanta Services pre-market up 3.72%; Lumentum pre-market up 3.43%; Nuwellis pre-market up 104.17%; T3 Defense pre-market up 63.62%; China Su Xuan Tang Pharmaceutical pre-market up 59.24%
Pre-market Hot Trades in US Stocks
Quanta Services rose 3.72% in pre-market trading. Based on recent key news:
-
On July 27, analysts estimated Quanta Services' quarterly earnings per share to be $3.31, with revenue of $8.59 billion. This expectation boosted market confidence in the company's performance, driving the stock price up.
-
On July 27, Quanta Services was rated as "Moderate Buy." Although some analysts believe that five other stocks have more investment value, the rating for Quanta Services still had a positive impact on its stock price.
-
On July 29, after a 5.2% drop in the previous trading day, Quanta Services' stock price rebounded, with the market remaining optimistic about its future performance. Increased demand in the AI industry has driven up the stock prices of related companies.
Lumentum rose 3.43% in pre-market trading. Based on recent key news:
-
On July 30, Lumentum signed a long-term supply agreement with AXT to ensure future supply of indium phosphide wafers. This move is seen by the market as a measure to reduce future supply tightness risks, driving the stock price up. Source: Business Wire
-
On July 28, Corning's stock price plummeted after its earnings report, dragging down the stocks of optical communication components. Lumentum's stock price fell over 10% as a result. Source: MarketBeat
-
On July 27, Lumentum CEO Michael Hurlston received the 2026 Optica i4 Personal Achievement Award, enhancing the company's reputation. Source: Business Wire The demand in the optical communication industry is growing, driven by the expansion of AI data centers.
Top Gainers in Pre-market US Stocks
Nuwellis rose 104.17% in pre-market trading. Based on recent key news:
-
On July 27, Nuwellis announced a preliminary revenue growth of 14% for the second quarter of 2026, significantly boosting the stock price. The company stated that this growth was mainly due to the commercial success of the Aquadex ultrafiltration platform.
-
On July 27, Nuwellis announced a year-on-year revenue growth of 20% for the first half of 2026, further enhancing market confidence. The company plans to release its complete second-quarter earnings report on August 13.
-
On July 27, Nuwellis' preliminary earnings results showed strong revenue growth, attracting investor attention and driving the stock price up. The medical device industry has performed strongly recently.
T3 Defense rose 63.62% in pre-market trading. Based on recent key news:
-
On July 29, T3 Defense completed a 1-for-125 reverse stock split, reducing the float to 1.12 million shares, triggering a technical short squeeze. At the same time, the company made progress in its Project 35 in the anti-drone technology field and achieved contract delivery, causing the stock price to surge by 81.56%. Source: Benzinga
-
On July 28, T3 Defense's subsidiary completed the delivery of an automated composite materials production line worth $1.1 million, further expanding its influence in the high-demand anti-drone technology sector. The stock price rose by 130.76%. Source: Benzinga
-
On July 30, T3 Defense experienced significant stock price fluctuations due to a low float and high trading volume, with an increase of 88%. Source: Benzinga The demand for anti-drone technology is growing, attracting high market attention.
China Su Xuan Tang Pharmaceutical, pre-market up 59.24%, has had no significant news recently. Trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation
